For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and Attruby represents a genuine breakthrough . These novel therapies preserve the transthyretin protein, halting its destructive build-up and reducing the severity of the illness. Individuals are now reporting positive ou